The present invention relates to substituted pyrazolopyridine compounds of general formula I as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
本发明涉及通式I所述的取代
吡唑吡啶化合物,以及制备该化合物的方法,用于制备该化合物的中间体化合物,包含该化合物的制药组合物和组合物,以及用于制造治疗或预防疾病的制药组合物的使用,特别是用作唯一的药剂或与其他活性成分结合使用,治疗或预防过度增生和/或血管生成障碍。